| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.08B | 62.01B | 23.61B | 21.31B | 20.78B | 19.86B |
| Gross Profit | 27.75B | 26.67B | 23.52B | 21.29B | 20.80B | 19.80B |
| EBITDA | 12.73B | 12.12B | 10.34B | 8.05B | 8.73B | 9.01B |
| Net Income | 9.36B | 8.43B | 7.12B | 5.00B | 6.22B | 6.43B |
Balance Sheet | ||||||
| Total Assets | 1.13T | 1.12T | 1.04T | 975.72B | 943.60B | 837.68B |
| Cash, Cash Equivalents and Short-Term Investments | 11.00B | 92.81B | 93.25B | 80.52B | 92.72B | 88.15B |
| Total Debt | 174.05B | 355.82B | 208.49B | 194.50B | 187.45B | 164.17B |
| Total Liabilities | 1.07T | 1.05T | 982.98B | 922.51B | 893.22B | 791.85B |
| Stockholders Equity | 65.32B | 64.13B | 58.73B | 52.98B | 50.18B | 45.65B |
Cash Flow | ||||||
| Free Cash Flow | -916.00M | 12.73B | 10.00B | 11.14B | 21.61B | -4.17B |
| Operating Cash Flow | 246.00M | 13.84B | 11.09B | 12.15B | 22.71B | -3.33B |
| Investing Cash Flow | -11.21B | -5.78B | -20.75B | -20.76B | -24.39B | -3.51B |
| Financing Cash Flow | 10.68B | -4.31B | -2.61B | -2.16B | -1.61B | -1.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $127.41B | 15.30 | 10.39% | 4.32% | -3.65% | -1.73% | |
69 Neutral | C$323.08B | 15.63 | 15.48% | 2.58% | 2.13% | 25.16% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | C$227.03B | 10.77 | 17.76% | 3.34% | 3.07% | 144.41% | |
64 Neutral | C$128.49B | 14.28 | 14.85% | 3.07% | -3.13% | 18.22% | |
62 Neutral | C$140.46B | 16.32 | 10.53% | 3.61% | -1.30% | 20.41% | |
58 Neutral | C$74.10B | 18.10 | 13.53% | 2.64% | 7.50% | -5.28% |